Atıf Formatları
The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Emirüyükaşık And B. GÜVENÇ, "The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications," Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting , vol.21, Texas, United States Of America, pp.423-424, 2024

Emirüyükaşık, E. And GÜVENÇ, B. 2024. The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications. Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting , (Texas, United States Of America), 423-424.

Emirüyükaşık, E., & GÜVENÇ, B., (2024). The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications . Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting (pp.423-424). Texas, United States Of America

Emirüyükaşık, Emir, And BİROL GÜVENÇ. "The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications," Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting, Texas, United States Of America, 2024

Emirüyükaşık, Emir And GÜVENÇ, BİROL. "The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications." Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting , Texas, United States Of America, pp.423-424, 2024

Emirüyükaşık, E. And GÜVENÇ, B. (2024) . "The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications." Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting , Texas, United States Of America, pp.423-424.

@conferencepaper{conferencepaper, author={Emir Emirüyükaşık And author={BİROL GÜVENÇ}, title={The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications}, congress name={Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting}, city={Texas}, country={United States Of America}, year={2024}, pages={423-424} }